Skip to main content

Diabetes Device News

Diabetes Devices monitor and help to manage your blood sugar levels to try to stay within the target range, helping prevent complications of diabetes.

BGM    CGM     Injection Pens     Insulin Pumps      AID

Strong results from the IMPACT study in low-A1c users.
What Abbott, Dexcom, LifeScan, Medtronic, Tandem, and others are bringing to make diabetes easier and less burdensome
Dexcom’s new insertion, Android G5, touchscreen receiver; Medtronic’s Android MiniMed Connect, Hypo Prediction App, 670G, and Guardian Connect.
A key step for obtaining Medicare coverage (hopefully expected in 2018), for increasing safety, and for encouraging CGM use
What to do if you have United insurance.
Highlights from the first study of a commercial automated insulin delivery device. Plus, Medtronic’s latest software updates!
Sept. 28 was a big day for diabetes tech approvals in the US – a big step in bringing the latest and greatest tech to people with diabetes!
Our own Kelly Close moderates a panel at SXSW Interactive.
Free for patients! Initially available in Austria and Germany, and soon in the US.
Significant Improvement in A1c and time-in-range when adding CGM.
Available in US physicians’ offices in the next couple weeks; Real-time version submitted to FDA!
Plus, a partnership with UCSF to drive better research.
Details for Dexcom July 21 Advisory Panel meeting posted. How to submit a written statement to the FDA or attend in person.
Adam Brown leads expert panel discussion at The diaTribe Foundation’s first-ever digital health gathering at ADA 2016.
Coming to US in Spring 2017: What it is, what it isn’t, and how to get it
Data from Bluetooth-enabled meter can now be shared with other health tracking apps.
Providers and patients will now see the same data - stay tuned for IBM Watson!
The Annual TCOYD/The diaTribe Foundation Forum Celebrates its 10 th Anniversary in New Orleans
$99 device makes pump and CGM data viewable to Android smartphone users. Plus, a first look at cool pattern recognition in the Sugar.IQ app with IBM Watson
Plus, Lilly invests $5 million! We talk to Dr. Ed Damiano to learn about the new Gen 3 version and upcoming studies.